Noble Roman's, Inc.
NROM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | 8.5% | 1.7% | -4.7% | – |
| Cost of Goods Sold | $3 | $3 | $2 | $3 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 34.4% | 27.4% | 32.8% | 28.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $1 |
| SG&A Expenses | $0 | $0 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $0 | $0 |
| % Margin | 22.4% | 13.3% | 1.8% | 10.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 9.1% | 3.5% | -4.5% | 5% |
| EPS | 0.017 | 0.006 | -0.009 | 0.009 |
| % Growth | 183.1% | 162.8% | -208% | – |
| EPS Diluted | 0.015 | 0.005 | -0.009 | 0.008 |
| Weighted Avg Shares Out | 22 | 22 | 22 | 22 |
| Weighted Avg Shares Out Dil | 25 | 25 | 22 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $0 | $1 |
| % Margin | 25.7% | 18.4% | 7.6% | 18.2% |